RYZUMI
Dead / Abandoned — Abandoned — no statement of use filed (as of 09 Oct 2025)
What this means for you
This application is over — abandoned 09 Oct 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97626125
- Mark type
- Stylized text
- Filed
- 10 Oct 2022
- Published for opposition
- 19 Dec 2023
- Abandoned
- 09 Oct 2025
- Attorney of record
- Glenn A. Gundersen
Goods and services
- Class 042 — Scientific and technological services: Research and development in the pharmaceutical field; consulting services in the field of pharmaceutical research and development; scientific research and development; scientific investigations for medical purposes; providing medical and scientific research information in the field of pharmaceuticals and clinical trials
Owner
- OCUPHIRE PHARMA, INC., Farmington Hills, MI, US
- OCUPHIRE PHARMA, INC., Farmington Hills, MI, US
Prosecution history
- 09 Oct 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 09 Oct 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 29 Jul 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 Jul 2024 — SOU EXTENSION 1 GRANTED
- 29 Jul 2024 — SOU EXTENSION 1 FILED
- 29 Jul 2024 — SOU TEAS EXTENSION RECEIVED
- 13 Feb 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 19 Dec 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 19 Dec 2023 — PUBLISHED FOR OPPOSITION
- 29 Nov 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 16 Nov 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 15 Nov 2023 — EXAMINER'S AMENDMENT ENTERED
- 15 Nov 2023 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 15 Nov 2023 — EXAMINERS AMENDMENT E-MAILED
- 15 Nov 2023 — EXAMINERS AMENDMENT -WRITTEN